Essential Amino Acids and High Intensity Interval Training

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-03-01

Study Completion Date

2020-01-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Purpose: The primary purpose is to determine the combined effects of essential amino acids (EAA) supplementation and high intensity interval training (HIIT) on body composition, muscle characteristics, and muscle architecture in overweight men and women over the course of eight weeks. A secondary purpose is to determine the metabolic effects of EAA supplementation and HIIT on whole body protein turnover, metabolic rate, substrate metabolism, and metabolomics. A tertiary purpose is to evaluate the modulatory effects of sex on body composition, metabolism, metabolic profile, cardiorespiratory fitness, and hunger and satiety in response to EAA supplementation and HIIT. Participants: Healthy overweight and obese men and women (30-50 years) Procedures (methods): In a block randomized design, 78 healthy, overweight or obese men and women will be randomized, to one of four, eight-week intervention groups using a 2:2:2:1 group allocation design: 1) essential amino acids (EAA) supplementation (7.2 grams EAA daily); 2) HIIT, two days per week of cycle ergometry training; 3) EAA + HIIT; or 4) control (CON), receiving no intervention. Measurements of body composition, muscle characteristics, resting metabolic rate, substrate metabolism, and cardiorespiratory fitness will be measured at baseline, 4-weeks, and 8-weeks. Metabolomics and whole body protein turnover will also be measured at baseline and 8-weeks. Subjects will be asked to arrive to testing sessions following a 12 hour fast (except for water), consuming no food, caffeine, or alcohol. Participants will also be asked to abstain from physical activity for 24 hours prior to testing. Subjects will complete one electronic contact (phone/email screening) and up to 22 in-person sessions (enrollment; 5 testing sessions \[2 at base, 1 at 4week, 2 at 8week\]; 16 training sessions \[for HIIT and EAA+HIIT\]) over the course of 8 weeks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Protein Supplementation and HIIT: Impact on Cardiorespiratory Fitness

NCT04359342

Primary Prevention Health Promotion

UNKNOWN NA

Impact of Amino Acids to Enhance Anabolism After Home-based Exercise

NCT04850820

Amino Acids, Essential Metabolism Exercise

COMPLETED NA

Essential Amino Acids and Protein Kinetics During Caloric Deprivation

NCT03372928

Muscle Protein Synthesis Whole-body Protein Balance

COMPLETED NA

Exercise and Branched Chain Amino Acids (BCAA)Requirements in Older Men

NCT01931722

Sarcopenia

SUSPENDED NA

Essential Amino Acids Supplementation and Muscle Protein Synthesis

NCT01366924

Muscle Loss Muscle Anabolism

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Risk Factor Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High intensity interval training (HIIT)

Group Type EXPERIMENTAL

High Intensity Interval Training

Intervention Type OTHER

Exercise

Essential Amino Acid Supplement

Group Type EXPERIMENTAL

Essential Amino Acid

Intervention Type DIETARY_SUPPLEMENT

Oral ingestion of a powdered dietary supplement

High intensity interval training + Essential Amino Acid

Group Type EXPERIMENTAL

High intensity interval training and essential amino acid supplement

Intervention Type OTHER

Exercise and dietary supplement

Control

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

High Intensity Interval Training

Exercise

Intervention Type OTHER

Essential Amino Acid

Oral ingestion of a powdered dietary supplement

Intervention Type DIETARY_SUPPLEMENT

High intensity interval training and essential amino acid supplement

Exercise and dietary supplement

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women (25-50 years).
* Overweight and obese: body mass index (BMI) of 27 - 40 kg·m-2 and/or percent body fat \> 25% for men, and BMI of 25 - 40 kg·m-2 and/or Percent Body Fat \> 30% for women.
* Healthy, non-smokers.
* Women: eumenorrheic, reporting consistent menstruation, having 3 regular cycles in the 3 months prior to enrollment, and not pregnant or planning on becoming pregnant.

Exclusion Criteria

* Have current and/or history of cardiovascular disease, diabetes, metabolic, thyroid, pulmonary, renal, hepatic, gastrointestinal, musculoskeletal disorders or medical or surgical events, such as bariatric surgery, heart surgery, or any joint or musculoskeletal surgeries occurring in the 6-months prior to enrollment, that may significantly influence study outcomes or prevent safe participation.
* Have uncontrolled hypertension or an abnormal electrocardiogram.
* Have a diagnosed mental disorder
* Inconsistently taking medications or taking medications that may influence study outcomes.
* Participating in more than 150 minutes per week of moderate exercise, more than 2 days per week of resistance training, or currently participating in high intensity interval training or participated in HIIT within the previous 12 weeks.
* Lost or gained greater than eight pounds within three months prior to the enrollment.
* Currently consuming a high protein diet (,1.6 g·kg-1·day-1 and \<25% of calories from protein).
* Currently consuming meal replacements or dietary supplements that may taurine, or beta-hydroxy beta-methylbutyrate) within eight weeks prior to the enrollment date.
* Reports any known sensitivity to the Essential Amino Acid treatment.
* Has participated in another clinical trial within four weeks prior to enrollment that in the opinion of the PI would influence the results.
* Has severely impaired hearing or speech or inability to speak English.
* Unwilling or unable to comply with the study protocol, including abstaining from, caffeine, tobacco, alcohol, and physical activity before testing days.

Minimum Eligible Age

30 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes